Leukemia

Dr. Richard Vile, a Mayo Clinic immunologist and cancer researcher, explains how CAR-T cell therapy works, including the benefits, risks and realities of treatment.

Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to reveal insights that improve patient care.

Dr. Sikander Ailawadhi says physicians are identifying, monitoring and eliminating blood cancer earlier thanks to new treatments.

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.

Dr. Kebede Begna, a hematologist, explains what treatment-free remission is and the criteria for determining if this approach is appropriate for people with CML.

Scott Brandes learned he had acute leukemia when his wife was pregnant. The hope of meeting the baby and supportive colleagues sustained him through treatment.

Researchers have uncovered a new reason CAR-T cell therapy fails in some patients, fueling new strategies to improve the treatment's outcome.

A new study shows people with monoclonal B-cell lymphocytosis (MBL) may have an elevated risk for several health complications, including melanoma.

Dr. Asmaa Ferdjallah, a pediatric hematologist-oncologist, shares what families need to know about the most common form of childhood cancer.

Study results showed significantly higher survival rates when blinatumomab was added to chemotherapy for people with B-cell acute lymphoblastic leukemia.